Literature DB >> 11456367

The use of antibiotics critical to human medicine in food-producing animals in Taiwan.

L C McDonald1, M T Chen, T L Lauderdale, M Ho.   

Abstract

There are increasing public health concerns about antibiotics used in food-producing animals that may contribute to the development of resistance in human pathogens. Such resistance may be critical to human medicine when resistance develops to drugs that treat certain pathogens of which there is no good alternative therapy. We surveyed 10 farms, eight feed mills, and one animal drug distributor in Taiwan to determine the major antibiotics used in food-producing animals, and the extent of use of five drugs that may select for resistance to antibiotics that are critical for human medicine. The five animal drugs, and the resistance of human drug/class they may select for, included avoparcin (vancomycin/glycopeptides), avilomycin (ziracin/envirninomycins), enrofloxacin (ciprofloxacin/fluoroquinolones), virginiamycin (quinupristin and dalfopristin combination/streptogramins), and kanamycin (gentamicin/aminoglycosides). Tetracyclines were the class of antibiotic that was most widely used in the greatest amounts. Over the past 12 months, the number of farms, chicken feed mills, and pig feed mills, that have respectively reported the use of avoparcin was 1 (10%), 5 (63%), 0; avilomycin 0, 0, 3 (50%); enrofloxacin 4 (40%), 1 (13%), 3 (50%); virginiamycin 2 (20%), 5 (63%), 0; and kanamycin 3 (30%), 1 (13%), 1 (17%). We conclude that although the most commonly used antibiotics (ie tetracyclines) have little effect on human medicine, there is a widespread use of antibiotics that may select for critical forms of resistance in human pathogens in food-producing animals.

Entities:  

Mesh:

Year:  2001        PMID: 11456367

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

1.  Antibiotic resistance pattern and gene expression of non-typhoid Salmonella in riversheds.

Authors:  Chao-Yu Hsu; Bing-Mu Hsu; Wen-Tsai Ji; Jung-Sheng Chen; Tsui-Kang Hsu; Dar-Der Ji; Shao-Feng Tseng; Yi-Chou Chiu; Po-Min Kao; Yu-Li Huang
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-07       Impact factor: 4.223

2.  Epidemiologic relationship between fluoroquinolone-resistant Salmonella enterica Serovar Choleraesuis strains isolated from humans and pigs in Taiwan (1997 to 2002).

Authors:  Chao-Chin Chang; Yi-Hsuan Lin; Chao-Fu Chang; Kuang-Sheng Yeh; Cheng-Hsun Chiu; Chishih Chu; Maw-Sheng Chien; Yuan-Man Hsu; Li-Shu Tsai; Chien-Shun Chiou
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Bacteraemia due to ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis in adult patients at a university hospital in Taiwan, 1996-2004.

Authors:  J-Y Wang; J-J Hwang; C-N Hsu; L-C Lin; P-R Hsueh
Journal:  Epidemiol Infect       Date:  2006-03-29       Impact factor: 2.451

4.  Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.

Authors:  L C McDonald; F J Chen; H J Lo; H C Yin; P L Lu; C H Huang; P Chen; T L Lauderdale; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

5.  In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum.

Authors:  Lin-Hui Su; Cheng-Hsun Chiu; Chishih Chu; Mei-Hui Wang; Ju-Hsin Chia; Tsu-Lan Wu
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Sung-Pin Tseng; Chao-Fu Chang; Jen-Hsien Wan; Jing-Jou Yan; Chun-Ming Lee; Yin-Ching Chuang; Wen-Kuei Huang; Dine Yang; Jainn-Ming Shyr; Kwok-Woon Yu; Li-Shin Wang; Jang-Jih Lu; Wen-Chien Ko; Jiunn-Jong Wu; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Cheng-Yi Liu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

7.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Decline of Salmonella enterica serotype Choleraesuis infections, Taiwan.

Authors:  Lin-Hui Su; Tsu-Lan Wu; Cheng-Hsun Chiu
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

9.  Prevalence of nontyphoidal Salmonella serogroups and their antimicrobial resistance patterns in a university teaching hospital in Eastern Province of Saudi Arabia.

Authors:  Nasreldin Elhadi; Reem Aljindan; Mohammed Aljeldah
Journal:  Infect Drug Resist       Date:  2013-11-22       Impact factor: 4.003

10.  Pattern of increased antimicrobial resistance of Salmonella isolates in the Eastern Province of KSA.

Authors:  Reem Y Aljindan; Khaled R Alkharsah
Journal:  J Taibah Univ Med Sci       Date:  2020-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.